Cart
sales@molnova.com
Thalifendine
CAS No. 18207-71-1
Thalifendine( —— )
Catalog No. M32252 CAS No. 18207-71-1
Thalifendine is a metabolite of Berberine, with antiplasmodial and antiamoebic activities.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 371 | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameThalifendine
-
NoteResearch use only, not for human use.
-
Brief DescriptionThalifendine is a metabolite of Berberine, with antiplasmodial and antiamoebic activities.
-
DescriptionThalifendine is a metabolite of Berberine, with antiplasmodial and antiamoebic activities.Thalifendine shows activities against P. falciparum and E. histolytica with IC50s of 7.91 μM and 116 μM, respectively.Thalifendine inhibited cytochrome P450 (CYP) 2D6.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number18207-71-1
-
Formula Weight322.33
-
Molecular FormulaC19H16NO4
-
Purity>98% (HPLC)
-
SolubilityDMSO, Pyridine, Methanol, Ethanol, etc.
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Remimazolam
Remimazolam is a benzodiazepine derivative drug as an alternative to the short-acting imidazobenzodiazepine midazolam, for use in induction of anaesthesia and conscious sedation for minor invasive procedures.?Remimazolam was found to be both faster acting and shorter lasting than midazolam, and human clinical trials showed a faster recovery time and predictable, consistent pharmacokinetics, suggesting some advantages over existing drugs for these applications.?
-
Disitamab vedotin
Disitamab vedotin (RC-48) is a newly developed antibody-active molecule conjugate (ADC) targeting human epidermal growth factor receptor 2 (HER2), consisting of hertuzumab coupled to monomethyl auristatin E (MMAE) via a cleavable linker.
-
[D-Pro2,D-Trp6,8,Nle...
(D-Pro2,D-Trp6,8,Nle10)-Neurokinin B is a competitive antagonist of Neurokinin B (Neurokinin Receptor) with a pA2 of 5.5. (D-Pro2,D-Trp6,8,Nle10)-Neurokinin B shows no influence on Substance P or Neurokinin A.
